Table 2 Chronic complications
Author years | Type of study/Number of patients | Mean age/Gender/underlying condition | Anatomical site of injury/trauma mechanism/type of injury | Type of repair | Results and follow-up |
|---|---|---|---|---|---|
Lin2 (2001) | Retrospective cohort (34 cases), 7 underwent surgery for CLI | 4.8 y (Range, 1 w to 17.4 y)/ M = 4, F = 3/NS | CLI (n = 7) CFA/NS | - Ileofemoral bypass with GSV (n = 5), - Femoro-femoral bypass with GSV (1), or CFA SVPA (n = 1) | Follow-up: 40.1 mo (range of 1.9 to 5.1 y), all patients with palpable pedal pulses |
Cardneau13 (2001) | Retrospective cohort of 12 | 7 y (range, 2 to 11 y)/M = 8, F = 4 | CLI secondary to stenosis due to DCC or TCC: - Left iliofemoral (n = 4) - Right iliofemoral (n = 6) - Right aortofemoral (n = 1) - Right femoropopliteal (n = 2) | - Iliofemoral bypass with GSV (n = 10) Aortofemoral bypass with GSV (n = 1) Femoro femoral bypass with GSV (n = 1) | Follow-up: 9.4 y (range of 1.6 to 25.1 y) Mean dilatation of GSV of 35% (range 0 to 50%) Mean ABI of 0.97 post bypass vs. 0.7 preoperatively (p < 0.05) and diminution of LLD |
Andraska3 (2017) | Retrospective cohort of 81, 7 underwent surgery for CLI | M = 3, F = 4/ 42 mo (range, 15 to 72)/NS | CLI secondary to stenosis due to DCC or TCC: - iliofemoral (n = 5) - CFA (n = 2) | Revascularization (n = 7): - Iliofemoral bypass with GSV (n = 5) - Iliofemoral bypass with PTFE (n = 1) - Femoral-SFA bypass with GSV(n = 1) | Follow-up: 50 mo (range, 1 to 118 mo) 2 graft stenosis, 1 reoperation due to graft occlusion 100% of limb salvage |
Schwartz15 (2020) | Case report/1 | 8 year F/AoCo | CLI secondary to stenosis of R EIA and CFA after TCC at 28 weeks for aortic coarctation | SFA and profunda femoris artery bypass with GSV with 8/0 polypropylene suture | Follow-up: 6 y (72 mo), bypass patency. And normal growth chart as expected |